[
    "{\"step_by_step_thinking\": \"To determine if dupilumab is effective for the treatment of asthma, we need to review the information provided in the relevant documents. Document [0] states that dupilumab is currently in phase III for moderate-to-severe asthma and is directed against the \u03b1-subunit of the interleukin (IL)-4 receptor. Document [1] mentions that dupilumab is a promising biological drug for the treatment of severe uncontrolled asthma. Document [3] states that dupilumab has shown significant efficacy and safety profile in patients with severe asthma with corticosteroid dependence. Document [8] mentions that dupilumab has been evaluated in phase 3 trials and has shown improvements in asthma control, lung function, and reduction in severe asthma exacerbations. Based on this information, it can be concluded that dupilumab is effective for the treatment of asthma.\", \"answer_choice\": \"A\"}"
]